|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
29 November 2021 |
|
Main ID: |
NCT04184453 |
|
Date of registration:
|
29/11/2019 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Clinical Curative Effect Evaluation Study of Treatment of Oral Deferiprone Tablets in Aceruloplasminaemia Patients
|
|
Scientific title:
|
Clinical Curative Effect Evaluation Study of Treatment of Oral Deferiprone Tablets in Aceruloplasminaemia Patients |
|
Date of first enrolment:
|
December 23, 2019 |
|
Target sample size:
|
5 |
|
Recruitment status: |
Recruiting |
|
URL:
|
https://clinicaltrials.gov/show/NCT04184453 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
|
|
Phase:
|
Early Phase 1
|
|
|
Countries of recruitment
|
|
China
| | | | | | | |
|
Contacts
|
|
Name:
|
Wanjin Chen |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Department of Neurology , First Affiliated Hospital Fujian Medical University |
|
|
Name:
|
HeJin |
|
Address:
|
|
|
Telephone:
|
13645050186 |
|
Email:
|
|
|
Affiliation:
|
|
|
|
Name:
|
Jin He |
|
Address:
|
|
|
Telephone:
|
13645050186 |
|
Email:
|
hejin@fjmu.edu.cn |
|
Affiliation:
|
|
|
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Age 18-80 years
- Diagnosed with aceruloplasminaemia
- Genetically confirmed diagnosis of aceruloplasminaemia
Exclusion Criteria:
- Contraindications to deferiprone therapy
- Pregnancy was excluded in women of childbearing age
Age minimum:
18 Years
Age maximum:
80 Years
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Aceruloplasminemia
|
|
Intervention(s)
|
|
Drug: Deferiprone treated
|
|
Primary Outcome(s)
|
|
Change of pancreas MRI
[Time Frame: Up to 3 months]
|
|
Change of glycated hemoglobin (HbA1c)
[Time Frame: Up to 3 months]
|
|
Secondary ID(s)
|
|
MRCTA,ECFAH of FMU [2019]252
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|